147 related articles for article (PubMed ID: 15952407)
1. Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease.
Scommegna S; Greening JP; Storr HL; Davies KM; Shaw NJ; Monson JP; Grossman AB; Savage MO
J Endocrinol Invest; 2005 Mar; 28(3):231-5. PubMed ID: 15952407
[TBL] [Abstract][Full Text] [Related]
2. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
[TBL] [Abstract][Full Text] [Related]
3. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
Storr HL; Plowman PN; Carroll PV; François I; Krassas GE; Afshar F; Besser GM; Grossman AB; Savage MO
J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
[TBL] [Abstract][Full Text] [Related]
4. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence.
Bonjour JP; Theintz G; Buchs B; Slosman D; Rizzoli R
J Clin Endocrinol Metab; 1991 Sep; 73(3):555-63. PubMed ID: 1874933
[TBL] [Abstract][Full Text] [Related]
5. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
[TBL] [Abstract][Full Text] [Related]
6. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
[TBL] [Abstract][Full Text] [Related]
7. Regional fat depots and their relationship to bone density and microarchitecture in young oligo-amenorrheic athletes.
Singhal V; Maffazioli GD; Cano Sokoloff N; Ackerman KE; Lee H; Gupta N; Clarke H; Slattery M; Bredella MA; Misra M
Bone; 2015 Aug; 77():83-90. PubMed ID: 25868796
[TBL] [Abstract][Full Text] [Related]
8. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
9. Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome.
Luisetto G; Zangari M; Camozzi V; Boscaro M; Sonino N; Fallo F
Osteoporos Int; 2001; 12(11):956-60. PubMed ID: 11804023
[TBL] [Abstract][Full Text] [Related]
10. Linear growth and final height after treatment for Cushing's disease in childhood.
Lebrethon MC; Grossman AB; Afshar F; Plowman PN; Besser GM; Savage MO
J Clin Endocrinol Metab; 2000 Sep; 85(9):3262-5. PubMed ID: 10999819
[TBL] [Abstract][Full Text] [Related]
11. Effects of Cushing disease on bone mineral density in a pediatric population.
Lodish MB; Hsiao HP; Serbis A; Sinaii N; Rothenbuhler A; Keil MF; Boikos SA; Reynolds JC; Stratakis CA
J Pediatr; 2010 Jun; 156(6):1001-1005. PubMed ID: 20223476
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO
Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
[TBL] [Abstract][Full Text] [Related]
13. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
Kapteijns-van Kordelaar S; Noordam K; Otten B; van den Bergh J
Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease.
Devoe DJ; Miller WL; Conte FA; Kaplan SL; Grumbach MM; Rosenthal SM; Wilson CB; Gitelman SE
J Clin Endocrinol Metab; 1997 Oct; 82(10):3196-202. PubMed ID: 9329338
[TBL] [Abstract][Full Text] [Related]
16. Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency.
Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3150-4. PubMed ID: 9745418
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.
Theintz G; Buchs B; Rizzoli R; Slosman D; Clavien H; Sizonenko PC; Bonjour JP
J Clin Endocrinol Metab; 1992 Oct; 75(4):1060-5. PubMed ID: 1400871
[TBL] [Abstract][Full Text] [Related]
18. Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome.
Savage MO; Lienhardt A; Lebrethon MC; Johnston LB; Huebner A; Grossman AB; Afshar F; Plowman PN; Besser GM
Horm Res; 2001; 55 Suppl 1():24-30. PubMed ID: 11408758
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
20. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]